nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—Large intestine polyp—Rivastigmine—Alzheimer's disease	0.0582	0.0648	CcSEcCtD
Mometasone—Skin striae—Donepezil—Alzheimer's disease	0.0258	0.0288	CcSEcCtD
Mometasone—Furunculosis—Rivastigmine—Alzheimer's disease	0.0172	0.0191	CcSEcCtD
Mometasone—Bacterial infection—Memantine—Alzheimer's disease	0.0162	0.018	CcSEcCtD
Mometasone—Bacterial infection—Rivastigmine—Alzheimer's disease	0.0158	0.0176	CcSEcCtD
Mometasone—Trauma—Rivastigmine—Alzheimer's disease	0.0153	0.0171	CcSEcCtD
Mometasone—Furuncle—Rivastigmine—Alzheimer's disease	0.0149	0.0166	CcSEcCtD
Mometasone—Cataract—Galantamine—Alzheimer's disease	0.0111	0.0124	CcSEcCtD
Mometasone—Glaucoma—Donepezil—Alzheimer's disease	0.0109	0.0121	CcSEcCtD
Mometasone—Otitis media—Donepezil—Alzheimer's disease	0.0106	0.0117	CcSEcCtD
Mometasone—Influenza-like symptoms—Memantine—Alzheimer's disease	0.0104	0.0116	CcSEcCtD
Mometasone—Influenza-like symptoms—Rivastigmine—Alzheimer's disease	0.0102	0.0114	CcSEcCtD
Mometasone—Haemoptysis—Memantine—Alzheimer's disease	0.0101	0.0112	CcSEcCtD
Mometasone—Glaucoma—Memantine—Alzheimer's disease	0.00991	0.011	CcSEcCtD
Mometasone—Glaucoma—Rivastigmine—Alzheimer's disease	0.00969	0.0108	CcSEcCtD
Mometasone—Otitis media—Memantine—Alzheimer's disease	0.00958	0.0107	CcSEcCtD
Mometasone—Contusion—Donepezil—Alzheimer's disease	0.00942	0.0105	CcSEcCtD
Mometasone—Otitis media—Rivastigmine—Alzheimer's disease	0.00937	0.0104	CcSEcCtD
Mometasone—Skin discolouration—Donepezil—Alzheimer's disease	0.0091	0.0101	CcSEcCtD
Mometasone—Stinging—Rivastigmine—Alzheimer's disease	0.00901	0.01	CcSEcCtD
Mometasone—Endocrine disorder—Memantine—Alzheimer's disease	0.009	0.01	CcSEcCtD
Mometasone—Dysphonia—Rivastigmine—Alzheimer's disease	0.00887	0.00987	CcSEcCtD
Mometasone—Gastroenteritis—Galantamine—Alzheimer's disease	0.00868	0.00966	CcSEcCtD
Mometasone—Cataract—Donepezil—Alzheimer's disease	0.00863	0.00961	CcSEcCtD
Mometasone—Injury—Galantamine—Alzheimer's disease	0.00837	0.00932	CcSEcCtD
Mometasone—Viral infection—Rivastigmine—Alzheimer's disease	0.00808	0.00899	CcSEcCtD
Mometasone—Skin discolouration—Rivastigmine—Alzheimer's disease	0.00808	0.00899	CcSEcCtD
Mometasone—Wheezing—Donepezil—Alzheimer's disease	0.00798	0.00888	CcSEcCtD
Mometasone—Cataract—Memantine—Alzheimer's disease	0.00784	0.00872	CcSEcCtD
Mometasone—Cataract—Rivastigmine—Alzheimer's disease	0.00767	0.00853	CcSEcCtD
Mometasone—Influenza like illness—Memantine—Alzheimer's disease	0.00724	0.00806	CcSEcCtD
Mometasone—Dermatitis contact—Rivastigmine—Alzheimer's disease	0.00721	0.00803	CcSEcCtD
Mometasone—Candida infection—Memantine—Alzheimer's disease	0.00712	0.00793	CcSEcCtD
Mometasone—Influenza like illness—Rivastigmine—Alzheimer's disease	0.00709	0.00789	CcSEcCtD
Mometasone—Ear pain—Donepezil—Alzheimer's disease	0.00699	0.00778	CcSEcCtD
Mometasone—Candida infection—Rivastigmine—Alzheimer's disease	0.00697	0.00776	CcSEcCtD
Mometasone—Gastroenteritis—Donepezil—Alzheimer's disease	0.00673	0.00749	CcSEcCtD
Mometasone—Injury—Donepezil—Alzheimer's disease	0.00649	0.00722	CcSEcCtD
Mometasone—Bronchitis—Galantamine—Alzheimer's disease	0.0064	0.00712	CcSEcCtD
Mometasone—Ear pain—Memantine—Alzheimer's disease	0.00635	0.00706	CcSEcCtD
Mometasone—Ear pain—Rivastigmine—Alzheimer's disease	0.00621	0.00691	CcSEcCtD
Mometasone—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.00618	0.00688	CcSEcCtD
Mometasone—Gastroenteritis—Memantine—Alzheimer's disease	0.00611	0.0068	CcSEcCtD
Mometasone—Gastroenteritis—Rivastigmine—Alzheimer's disease	0.00598	0.00665	CcSEcCtD
Mometasone—Injury—Memantine—Alzheimer's disease	0.00589	0.00656	CcSEcCtD
Mometasone—Urinary tract infection—Galantamine—Alzheimer's disease	0.00576	0.00642	CcSEcCtD
Mometasone—Injury—Rivastigmine—Alzheimer's disease	0.00576	0.00642	CcSEcCtD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR6—Alzheimer's disease	0.0056	0.058	CbGpPWpGaD
Mometasone—Epistaxis—Galantamine—Alzheimer's disease	0.00559	0.00623	CcSEcCtD
Mometasone—Rhinitis—Galantamine—Alzheimer's disease	0.00534	0.00594	CcSEcCtD
Mometasone—Nasopharyngitis—Donepezil—Alzheimer's disease	0.00533	0.00594	CcSEcCtD
Mometasone—Asthma—Donepezil—Alzheimer's disease	0.00515	0.00574	CcSEcCtD
Mometasone—Influenza—Donepezil—Alzheimer's disease	0.00515	0.00574	CcSEcCtD
Mometasone—Bronchitis—Donepezil—Alzheimer's disease	0.00496	0.00552	CcSEcCtD
Mometasone—Nasopharyngitis—Memantine—Alzheimer's disease	0.00484	0.00539	CcSEcCtD
Mometasone—Immune system disorder—Galantamine—Alzheimer's disease	0.00481	0.00535	CcSEcCtD
Mometasone—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.00474	0.00527	CcSEcCtD
Mometasone—Asthma—Memantine—Alzheimer's disease	0.00468	0.00521	CcSEcCtD
Mometasone—Influenza—Memantine—Alzheimer's disease	0.00468	0.00521	CcSEcCtD
Mometasone—Bronchospasm—Memantine—Alzheimer's disease	0.0046	0.00512	CcSEcCtD
Mometasone—Bronchospasm—Rivastigmine—Alzheimer's disease	0.0045	0.00501	CcSEcCtD
Mometasone—Bronchitis—Memantine—Alzheimer's disease	0.0045	0.00501	CcSEcCtD
Mometasone—Back pain—Galantamine—Alzheimer's disease	0.00448	0.00499	CcSEcCtD
Mometasone—Conjunctivitis—Donepezil—Alzheimer's disease	0.00447	0.00497	CcSEcCtD
Mometasone—Urinary tract infection—Donepezil—Alzheimer's disease	0.00447	0.00497	CcSEcCtD
Mometasone—Bronchitis—Rivastigmine—Alzheimer's disease	0.0044	0.0049	CcSEcCtD
Mometasone—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00435	0.00484	CcSEcCtD
Mometasone—Epistaxis—Donepezil—Alzheimer's disease	0.00434	0.00483	CcSEcCtD
Mometasone—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00426	0.00474	CcSEcCtD
Mometasone—Rhinitis—Donepezil—Alzheimer's disease	0.00414	0.0046	CcSEcCtD
Mometasone—Pharyngitis—Donepezil—Alzheimer's disease	0.00409	0.00456	CcSEcCtD
Mometasone—Conjunctivitis—Memantine—Alzheimer's disease	0.00406	0.00452	CcSEcCtD
Mometasone—Urinary tract infection—Memantine—Alzheimer's disease	0.00406	0.00452	CcSEcCtD
Mometasone—Cough—Galantamine—Alzheimer's disease	0.00404	0.0045	CcSEcCtD
Mometasone—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00397	0.00442	CcSEcCtD
Mometasone—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00397	0.00442	CcSEcCtD
Mometasone—Chest pain—Galantamine—Alzheimer's disease	0.00395	0.00439	CcSEcCtD
Mometasone—Myalgia—Galantamine—Alzheimer's disease	0.00395	0.00439	CcSEcCtD
Mometasone—Arthralgia—Galantamine—Alzheimer's disease	0.00395	0.00439	CcSEcCtD
Mometasone—Epistaxis—Memantine—Alzheimer's disease	0.00394	0.00438	CcSEcCtD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—TTR—Alzheimer's disease	0.00392	0.0406	CbGpPWpGaD
Mometasone—Sinusitis—Memantine—Alzheimer's disease	0.00392	0.00436	CcSEcCtD
Mometasone—Dry mouth—Galantamine—Alzheimer's disease	0.00386	0.0043	CcSEcCtD
Mometasone—Epistaxis—Rivastigmine—Alzheimer's disease	0.00385	0.00429	CcSEcCtD
Mometasone—Sinusitis—Rivastigmine—Alzheimer's disease	0.00383	0.00426	CcSEcCtD
Mometasone—Rhinitis—Memantine—Alzheimer's disease	0.00376	0.00418	CcSEcCtD
Mometasone—Pharyngitis—Memantine—Alzheimer's disease	0.00372	0.00414	CcSEcCtD
Mometasone—Rhinitis—Rivastigmine—Alzheimer's disease	0.00367	0.00409	CcSEcCtD
Mometasone—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00364	0.00405	CcSEcCtD
Mometasone—Anorexia—Galantamine—Alzheimer's disease	0.00361	0.00401	CcSEcCtD
Mometasone—Back pain—Donepezil—Alzheimer's disease	0.00347	0.00387	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00345	0.00384	CcSEcCtD
Mometasone—Paraesthesia—Galantamine—Alzheimer's disease	0.0034	0.00378	CcSEcCtD
Mometasone—Immune system disorder—Memantine—Alzheimer's disease	0.00338	0.00377	CcSEcCtD
Mometasone—Mediastinal disorder—Memantine—Alzheimer's disease	0.00338	0.00376	CcSEcCtD
Mometasone—Dyspepsia—Galantamine—Alzheimer's disease	0.00333	0.00371	CcSEcCtD
Mometasone—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.0033	0.00368	CcSEcCtD
Mometasone—Decreased appetite—Galantamine—Alzheimer's disease	0.00329	0.00366	CcSEcCtD
Mometasone—Fatigue—Galantamine—Alzheimer's disease	0.00326	0.00363	CcSEcCtD
Mometasone—Back pain—Memantine—Alzheimer's disease	0.00315	0.00351	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—CELF1—Alzheimer's disease	0.00314	0.0325	CbGpPWpGaD
Mometasone—Cough—Donepezil—Alzheimer's disease	0.00313	0.00349	CcSEcCtD
Mometasone—CYP2C8—CYP2E1 reactions—CYP2D6—Alzheimer's disease	0.00313	0.0324	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00309	0.00344	CcSEcCtD
Mometasone—Back pain—Rivastigmine—Alzheimer's disease	0.00309	0.00344	CcSEcCtD
Mometasone—Myalgia—Donepezil—Alzheimer's disease	0.00306	0.0034	CcSEcCtD
Mometasone—Arthralgia—Donepezil—Alzheimer's disease	0.00306	0.0034	CcSEcCtD
Mometasone—Chest pain—Donepezil—Alzheimer's disease	0.00306	0.0034	CcSEcCtD
Mometasone—Dry mouth—Donepezil—Alzheimer's disease	0.00299	0.00333	CcSEcCtD
Mometasone—Abdominal pain—Galantamine—Alzheimer's disease	0.00299	0.00333	CcSEcCtD
Mometasone—Body temperature increased—Galantamine—Alzheimer's disease	0.00299	0.00333	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—PPP5C—Alzheimer's disease	0.00292	0.0303	CbGpPWpGaD
Mometasone—Infection—Donepezil—Alzheimer's disease	0.00291	0.00324	CcSEcCtD
Mometasone—Cough—Memantine—Alzheimer's disease	0.00285	0.00317	CcSEcCtD
Mometasone—Anorexia—Donepezil—Alzheimer's disease	0.00279	0.00311	CcSEcCtD
Mometasone—Cough—Rivastigmine—Alzheimer's disease	0.00278	0.0031	CcSEcCtD
Mometasone—Myalgia—Memantine—Alzheimer's disease	0.00278	0.00309	CcSEcCtD
Mometasone—Chest pain—Memantine—Alzheimer's disease	0.00278	0.00309	CcSEcCtD
Mometasone—Arthralgia—Memantine—Alzheimer's disease	0.00278	0.00309	CcSEcCtD
Mometasone—Myalgia—Rivastigmine—Alzheimer's disease	0.00272	0.00302	CcSEcCtD
Mometasone—Arthralgia—Rivastigmine—Alzheimer's disease	0.00272	0.00302	CcSEcCtD
Mometasone—Chest pain—Rivastigmine—Alzheimer's disease	0.00272	0.00302	CcSEcCtD
Mometasone—Dry mouth—Memantine—Alzheimer's disease	0.00272	0.00302	CcSEcCtD
Mometasone—Asthenia—Galantamine—Alzheimer's disease	0.00271	0.00302	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00267	0.00297	CcSEcCtD
Mometasone—Dry mouth—Rivastigmine—Alzheimer's disease	0.00266	0.00296	CcSEcCtD
Mometasone—Infection—Memantine—Alzheimer's disease	0.00264	0.00294	CcSEcCtD
Mometasone—Paraesthesia—Donepezil—Alzheimer's disease	0.00263	0.00293	CcSEcCtD
Mometasone—Dyspnoea—Donepezil—Alzheimer's disease	0.00261	0.00291	CcSEcCtD
Mometasone—Diarrhoea—Galantamine—Alzheimer's disease	0.00259	0.00288	CcSEcCtD
Mometasone—Infection—Rivastigmine—Alzheimer's disease	0.00259	0.00288	CcSEcCtD
Mometasone—Dyspepsia—Donepezil—Alzheimer's disease	0.00258	0.00287	CcSEcCtD
Mometasone—Decreased appetite—Donepezil—Alzheimer's disease	0.00255	0.00284	CcSEcCtD
Mometasone—Anorexia—Memantine—Alzheimer's disease	0.00254	0.00282	CcSEcCtD
Mometasone—Fatigue—Donepezil—Alzheimer's disease	0.00253	0.00281	CcSEcCtD
Mometasone—Pain—Donepezil—Alzheimer's disease	0.00251	0.00279	CcSEcCtD
Mometasone—Anorexia—Rivastigmine—Alzheimer's disease	0.00248	0.00276	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00242	0.0027	CcSEcCtD
Mometasone—Vomiting—Galantamine—Alzheimer's disease	0.0024	0.00268	CcSEcCtD
Mometasone—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.0024	0.00267	CcSEcCtD
Mometasone—Paraesthesia—Memantine—Alzheimer's disease	0.00239	0.00266	CcSEcCtD
Mometasone—Rash—Galantamine—Alzheimer's disease	0.00238	0.00265	CcSEcCtD
Mometasone—Dermatitis—Galantamine—Alzheimer's disease	0.00238	0.00265	CcSEcCtD
Mometasone—Dyspnoea—Memantine—Alzheimer's disease	0.00237	0.00264	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00237	0.00264	CcSEcCtD
Mometasone—Headache—Galantamine—Alzheimer's disease	0.00237	0.00264	CcSEcCtD
Mometasone—Dyspepsia—Memantine—Alzheimer's disease	0.00234	0.00261	CcSEcCtD
Mometasone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00234	0.0026	CcSEcCtD
Mometasone—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00232	0.00258	CcSEcCtD
Mometasone—Abdominal pain—Donepezil—Alzheimer's disease	0.00232	0.00258	CcSEcCtD
Mometasone—Body temperature increased—Donepezil—Alzheimer's disease	0.00232	0.00258	CcSEcCtD
Mometasone—Decreased appetite—Memantine—Alzheimer's disease	0.00231	0.00258	CcSEcCtD
Mometasone—Fatigue—Memantine—Alzheimer's disease	0.00229	0.00255	CcSEcCtD
Mometasone—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00229	0.00255	CcSEcCtD
Mometasone—Pain—Memantine—Alzheimer's disease	0.00228	0.00253	CcSEcCtD
Mometasone—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00226	0.00252	CcSEcCtD
Mometasone—Nausea—Galantamine—Alzheimer's disease	0.00225	0.0025	CcSEcCtD
Mometasone—Fatigue—Rivastigmine—Alzheimer's disease	0.00224	0.0025	CcSEcCtD
Mometasone—Pain—Rivastigmine—Alzheimer's disease	0.00223	0.00248	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—Alzheimer's disease	0.00218	0.0226	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00218	0.00242	CcSEcCtD
Mometasone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00213	0.00237	CcSEcCtD
Mometasone—Abdominal pain—Memantine—Alzheimer's disease	0.0021	0.00234	CcSEcCtD
Mometasone—Body temperature increased—Memantine—Alzheimer's disease	0.0021	0.00234	CcSEcCtD
Mometasone—Asthenia—Donepezil—Alzheimer's disease	0.0021	0.00234	CcSEcCtD
Mometasone—Pruritus—Donepezil—Alzheimer's disease	0.00207	0.00231	CcSEcCtD
Mometasone—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00206	0.00229	CcSEcCtD
Mometasone—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00206	0.00229	CcSEcCtD
Mometasone—Diarrhoea—Donepezil—Alzheimer's disease	0.00201	0.00223	CcSEcCtD
Mometasone—CYP2C8—Xenobiotics—CYP2D6—Alzheimer's disease	0.00194	0.0201	CbGpPWpGaD
Mometasone—Asthenia—Memantine—Alzheimer's disease	0.00191	0.00213	CcSEcCtD
Mometasone—Pruritus—Memantine—Alzheimer's disease	0.00188	0.0021	CcSEcCtD
Mometasone—Asthenia—Rivastigmine—Alzheimer's disease	0.00187	0.00208	CcSEcCtD
Mometasone—CYP2C8—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.00186	0.0193	CbGpPWpGaD
Mometasone—Vomiting—Donepezil—Alzheimer's disease	0.00186	0.00207	CcSEcCtD
Mometasone—Rash—Donepezil—Alzheimer's disease	0.00185	0.00206	CcSEcCtD
Mometasone—Dermatitis—Donepezil—Alzheimer's disease	0.00185	0.00206	CcSEcCtD
Mometasone—Pruritus—Rivastigmine—Alzheimer's disease	0.00184	0.00205	CcSEcCtD
Mometasone—Headache—Donepezil—Alzheimer's disease	0.00184	0.00204	CcSEcCtD
Mometasone—Diarrhoea—Memantine—Alzheimer's disease	0.00182	0.00203	CcSEcCtD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.00182	0.0188	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CDK5—Alzheimer's disease	0.00181	0.0187	CbGpPWpGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.00179	0.0186	CbGpPWpGaD
Mometasone—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00178	0.00198	CcSEcCtD
Mometasone—Nausea—Donepezil—Alzheimer's disease	0.00174	0.00194	CcSEcCtD
Mometasone—Vomiting—Memantine—Alzheimer's disease	0.00169	0.00188	CcSEcCtD
Mometasone—Rash—Memantine—Alzheimer's disease	0.00168	0.00187	CcSEcCtD
Mometasone—Dermatitis—Memantine—Alzheimer's disease	0.00168	0.00187	CcSEcCtD
Mometasone—Headache—Memantine—Alzheimer's disease	0.00167	0.00186	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—LEP—Alzheimer's disease	0.00166	0.0172	CbGpPWpGaD
Mometasone—Vomiting—Rivastigmine—Alzheimer's disease	0.00166	0.00184	CcSEcCtD
Mometasone—Rash—Rivastigmine—Alzheimer's disease	0.00164	0.00183	CcSEcCtD
Mometasone—Dermatitis—Rivastigmine—Alzheimer's disease	0.00164	0.00183	CcSEcCtD
Mometasone—Headache—Rivastigmine—Alzheimer's disease	0.00163	0.00182	CcSEcCtD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—Alzheimer's disease	0.0016	0.0166	CbGpPWpGaD
Mometasone—Nausea—Memantine—Alzheimer's disease	0.00158	0.00176	CcSEcCtD
Mometasone—Nausea—Rivastigmine—Alzheimer's disease	0.00155	0.00172	CcSEcCtD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.00147	0.0153	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—Alzheimer's disease	0.00145	0.015	CbGpPWpGaD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—Alzheimer's disease	0.00144	0.0149	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—CREB1—Alzheimer's disease	0.00143	0.0148	CbGpPWpGaD
Mometasone—Triamcinolone—BCHE—Alzheimer's disease	0.00128	0.247	CrCbGaD
Mometasone—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—Alzheimer's disease	0.00127	0.0132	CbGpPWpGaD
Mometasone—Fluoxymesterone—ESR1—Alzheimer's disease	0.00124	0.239	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.00118	0.0122	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—APP—Alzheimer's disease	0.00112	0.0116	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—PPARGC1A—Alzheimer's disease	0.00105	0.0108	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptors—ESR1—Alzheimer's disease	0.00102	0.0106	CbGpPWpGaD
Mometasone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—Alzheimer's disease	0.00102	0.0106	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.001	0.0104	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.001	0.0104	CbGpPWpGaD
Mometasone—Dexamethasone—NOS2—Alzheimer's disease	0.000978	0.189	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000972	0.0101	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—Alzheimer's disease	0.000971	0.0101	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.00095	0.00985	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—MEF2C—Alzheimer's disease	0.000944	0.00979	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptors—PPARG—Alzheimer's disease	0.000935	0.00969	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—Alzheimer's disease	0.0009	0.00933	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000878	0.0091	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000853	0.00885	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—Alzheimer's disease	0.00082	0.0085	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—Alzheimer's disease	0.000815	0.00845	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—ESR1—Alzheimer's disease	0.00081	0.00839	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000805	0.00835	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000802	0.00832	CbGpPWpGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000794	0.00824	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000787	0.00816	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP46A1—Alzheimer's disease	0.000782	0.00811	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000771	0.00799	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—Alzheimer's disease	0.000769	0.00797	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.000739	0.00766	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.00072	0.00747	CbGpPWpGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—GSK3B—Alzheimer's disease	0.000712	0.00738	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.000692	0.00718	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—BAX—Alzheimer's disease	0.000687	0.00712	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—CREB1—Alzheimer's disease	0.000686	0.00711	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—PLAU—Alzheimer's disease	0.000668	0.00692	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000665	0.0069	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000654	0.00678	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000653	0.00677	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000647	0.0067	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—ESR1—Alzheimer's disease	0.000628	0.00652	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—NOTCH1—Alzheimer's disease	0.000622	0.00645	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—Alzheimer's disease	0.00062	0.00643	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000608	0.0063	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000591	0.00613	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000591	0.00613	CbGpPWpGaD
Mometasone—Triamcinolone—PTGS2—Alzheimer's disease	0.000589	0.114	CrCbGaD
Mometasone—NR3C1—AP-1 transcription factor network—CREB1—Alzheimer's disease	0.000565	0.00586	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.000559	0.0058	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CCL2—Alzheimer's disease	0.000553	0.00574	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—PPARGC1A—Alzheimer's disease	0.000526	0.00545	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.000503	0.00522	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—Alzheimer's disease	0.000502	0.00521	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CREB1—Alzheimer's disease	0.000498	0.00517	CbGpPWpGaD
Mometasone—Betamethasone—PTGS2—Alzheimer's disease	0.000482	0.0931	CrCbGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	0.000481	0.00498	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—LPL—Alzheimer's disease	0.000479	0.00496	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—MEF2C—Alzheimer's disease	0.000474	0.00492	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—MAOB—Alzheimer's disease	0.000466	0.00484	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000454	0.00471	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.00045	0.00467	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000441	0.00458	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.000424	0.00439	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.00041	0.00425	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—LEP—Alzheimer's disease	0.000401	0.00416	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.000392	0.00406	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000373	0.00387	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000364	0.00377	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PHF1—Alzheimer's disease	0.000355	0.00368	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—PTGS1—Alzheimer's disease	0.000354	0.00367	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—PPARG—Alzheimer's disease	0.000349	0.00362	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP2D6—Alzheimer's disease	0.000347	0.00359	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—CREB1—Alzheimer's disease	0.000345	0.00357	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—INS—Alzheimer's disease	0.000343	0.00355	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000342	0.00355	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Alzheimer's disease	0.000339	0.00351	CbGpPWpGaD
Mometasone—Dexamethasone—CYP2D6—Alzheimer's disease	0.000334	0.0645	CrCbGaD
Mometasone—NR3C1—Endoderm Differentiation—TGFB1—Alzheimer's disease	0.000334	0.00346	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IGF1—Alzheimer's disease	0.000331	0.00344	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	0.000329	0.00341	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TGFB1—Alzheimer's disease	0.000326	0.00338	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000325	0.00337	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.0003	0.00311	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000298	0.00309	CbGpPWpGaD
Mometasone—Dexamethasone—PTGS2—Alzheimer's disease	0.000281	0.0541	CrCbGaD
Mometasone—NR3C1—AP-1 transcription factor network—TP53—Alzheimer's disease	0.000268	0.00278	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL6—Alzheimer's disease	0.000246	0.00255	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—Alzheimer's disease	0.000236	0.00245	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—TFAM—Alzheimer's disease	0.000229	0.00237	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.000221	0.00229	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.00022	0.00229	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—Alzheimer's disease	0.000216	0.00224	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	0.000202	0.00209	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—DHCR24—Alzheimer's disease	0.0002	0.00208	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—Alzheimer's disease	0.0002	0.00207	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—TGFB1—Alzheimer's disease	0.000199	0.00206	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000187	0.00194	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000187	0.00194	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—TNF—Alzheimer's disease	0.000186	0.00192	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CA4—Alzheimer's disease	0.00017	0.00177	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000167	0.00173	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.00016	0.00166	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GAPDHS—Alzheimer's disease	0.00016	0.00166	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ATP5A1—Alzheimer's disease	0.000152	0.00157	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IL6—Alzheimer's disease	0.00015	0.00155	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PLD3—Alzheimer's disease	0.000145	0.0015	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000145	0.0015	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000143	0.00148	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.00014	0.00145	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HSD17B10—Alzheimer's disease	0.000139	0.00144	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—EIF2S1—Alzheimer's disease	0.000138	0.00143	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000136	0.00141	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.000135	0.0014	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP46A1—Alzheimer's disease	0.000134	0.00139	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000129	0.00134	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ND1—Alzheimer's disease	0.000129	0.00134	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.000128	0.00132	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000126	0.00131	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000115	0.0012	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	9.95e-05	0.00103	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	9.06e-05	0.000939	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CHAT—Alzheimer's disease	8.32e-05	0.000863	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—TPI1—Alzheimer's disease	8.32e-05	0.000863	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MAOB—Alzheimer's disease	7.98e-05	0.000827	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	7.68e-05	0.000796	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	7.59e-05	0.000787	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	7.52e-05	0.00078	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—A2M—Alzheimer's disease	7.42e-05	0.000769	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ESR1—Alzheimer's disease	6.73e-05	0.000698	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	6.61e-05	0.000686	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—NOTCH1—Alzheimer's disease	6.51e-05	0.000675	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ACHE—Alzheimer's disease	6.45e-05	0.000669	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	6.38e-05	0.000661	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PPARG—Alzheimer's disease	6.14e-05	0.000637	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	6.05e-05	0.000627	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ENO1—Alzheimer's disease	6.05e-05	0.000627	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	5.93e-05	0.000615	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—BCHE—Alzheimer's disease	5.62e-05	0.000583	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	5.3e-05	0.00055	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.2e-05	0.000539	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	5.14e-05	0.000533	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	4.43e-05	0.000459	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	4.41e-05	0.000457	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LPL—Alzheimer's disease	4.03e-05	0.000418	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	3.63e-05	0.000377	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CALM1—Alzheimer's disease	3.39e-05	0.000352	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—APOE—Alzheimer's disease	3.38e-05	0.000351	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CAV1—Alzheimer's disease	3.35e-05	0.000347	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPARG—Alzheimer's disease	2.95e-05	0.000305	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—INS—Alzheimer's disease	2.89e-05	0.000299	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NOS3—Alzheimer's disease	2.53e-05	0.000263	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—AKT1—Alzheimer's disease	2.43e-05	0.000252	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	2.32e-05	0.00024	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AKT1—Alzheimer's disease	1.16e-05	0.000121	CbGpPWpGaD
